Special Issue "Phage Diversity for Research and Application"
Deadline for manuscript submissions: closed (1 June 2020) | Viewed by 29368
Interests: support of political and regulative strategies to foster phage therapy implementation in Germany and Europe; networking with policy-makers and with the national licensing authority; cooperation with medical doctors
Since we entered the post-antibiotic era, bacteriophages have resurfaced as one promising alternative to antibiotics and are now the focus of interest for application and general research again.
Bacteriophages are the most abundant biological entities on earth, with an estimated number of 4.8 × 1031 phage particles in the whole biosphere. Several sequencing projects analyzing the metagenomes of different habitats have revealed that the diversity of bacterial viruses is huge, and there is always something new to discover, with a lot of habitats and bacterial species still underrepresented in terms of phage research. Phages are probably the main drivers of evolution and powerfully contribute to biodiversity in the microbe world, including human and animal microbiomes, plants, and the rhizosphere or marine habitats.
In addition to their impact on ecology and evolution, they have also played an important role in the development of modern molecular biology, and research is still going on to find new ways to use phage diversity for different applications. Phages are a success story of nature and have served as appreciated model systems, including for human disease.
The Special Issue "Phage Diversity for Research and Application" will give phage researchers the opportunity to share their findings and discussion with the scientific community in the life sciences and will encourage them to initiate new thinktanks towards promoting infrastructures and funding bodies. General phage diversity and different aspects of phage biology should be addressed and various submission types, including original research papers, short communications, reviews, and perspectives are welcome, such as:
- Phage diversity studies
- Phages of fastidious host bacteria or in underexplored habitats
- Phages as tools
- Phages for different applications apart from phage therapy
- Phage lysis mechanisms and kinetics
- Phage host interactions and receptor studies
- Phages in the One Health context
Dr. Christine Rohde
Dr. Johannes Wittmann
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.